Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CTLA4
Pharma
Regeneron's Libtayo delivers lung cancer win with BMS' Yervoy
In this trial, Regeneron stopped the Libatyo-Yervoy-chemo arm early to focus on the sans-Yervoy regimen.
Angus Liu
Dec 1, 2022 12:25pm
ESMO: Exelixis faces uphill battle with kidney cancer triplet
Sep 12, 2022 10:30am
AZ's R&D chiefs talk roxadustat, Imfinzi-treme
Feb 10, 2022 10:13am
AZ oncology R&D chief marks Imfinzi as 'core backbone'
Jan 20, 2022 2:40pm
AZ finds treme a place alongside Imfinzi in liver cancer
Jan 18, 2022 5:00pm
Opdivo-Yervoy, Bavencio fail in head and neck cancer
Sep 20, 2021 7:30am